BACKGROUND: Prostate-specific antigen (PSA) testing remains the cornerstone of early prostate cancer detection. Society guidelines for prostate cancer screening via PSA testing serve to standardize patient care and are often used by trainees, junior ...
Accurate detection and classification of clinically significant prostate cancer remain critical challenges in medical imaging. Despite numerous studies focusing on feature extraction and classification, none have systematically assessed the impact of...
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Nov 3, 2025
This study aimed to explore the prognostic value of the artificial intelligence-assisted lesion tracking applied to prostate-specific membrane antigen (PSMA) PET in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with PS...
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Nov 3, 2025
Metastatic castration-resistant prostate cancer has a high rate of mortality with a limited number of effective treatments after hormone therapy. Radiopharmaceutical therapy with [Lu]Lu-prostate-specific membrane antigen-617 (LuPSMA) is one treatment...
Proposed methods for prostate cancer screening are currently prohibitively expensive (due to the high costs of imaging equipment such as magnetic resonance imaging and traditional ultrasound systems), inadequate in their detection rates, require high...
Robotic-assisted radical prostatectomy (RARP) has become the gold standard treatment for localized prostate cancer. However, predicting post-operative outcomes remains challenging. This study aims to develop and validate predictive models for key out...
Prostate cancer remains a significant public health concern, with a substantial proportion of patients experiencing biochemical recurrence (BCR) after radical prostatectomy (RP). Traditional risk models, such as CAPRA-S, have demonstrated moderate pr...
Diagnostic needle biopsies that miss clinically significant prostate cancer (PCa) often sample benign tissue near hidden cancers. Such benign samples might still display subtle morphological signs of cancer elsewhere in the prostate. This study exami...
Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society
Aug 11, 2025
Prostate cancer (PCa) detection and accurate grading remain critical challenges in medical diagnostics. While deep learning has shown promise in medical image analysis, existing computer-aided diagnosis approaches primarily focus on image recognition...
This study aims to investigate the diagnostic value of integrating multi-parametric magnetic resonance imaging (mpMRI) radiomic features with tumor abnormal protein (TAP) and clinical characteristics for diagnosing prostate cancer. A cohort of 109 pa...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.